Exploitation of Necrosis Avidity: from Diagnostics to Theragnostics in Oncology
暂无分享,去创建一个
Y. Ni | G. Marchal | J. Nuyts | G. Bormans | Feng Chen | A. Verbruggen | P. Witte | K. Prinsen | M. Cona | Junjie Li | Huaijun Wang | Jian Zhang | Lin Zhou | Ziping Sun | T. Marysael
[1] Hilde Bosmans,et al. Treatment of Rodent Liver Tumor With Combretastatin A4 Phosphate: Noninvasive Therapeutic Evaluation Using Multiparametric Magnetic Resonance Imaging in Correlation With Microangiography and Histology , 2008, Investigative radiology.
[2] Yicheng Ni,et al. Metalloporphyrins and Functional Analogues as MRI Contrast Agents , 2008 .
[3] G. Rustin,et al. Vascular damaging agents. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[4] S. Mulier,et al. A review of the general aspects of radiofrequency ablation , 2005, Abdominal Imaging.
[5] A. Epstein,et al. Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody. , 1989, Cancer research.